AllianceBernstein
ABEO icon

AllianceBernstein’s Abeona Therapeutics ABEO Stock Holding History

AllianceBernstein’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.4K Hold
17,920
– – ﹤0.01% 3159
2025
Q4 		$94.4K Hold
17,920
– – ﹤0.01% 3172
2025
Q3 		$94.6K Hold
17,920
– – ﹤0.01% 3186
2025
Q2 		$102K Buy
+17,920
New +$102K ﹤0.01% 3169
2021
Q2 		– Sell
-4,844
Closed -$228K – 3318
2021
Q1 		$228K Hold
4,844
– – ﹤0.01% 3010
2020
Q4 		$190K Hold
4,844
– – ﹤0.01% 3001
2020
Q3 		$124K Sell
4,844
-440
-8% -$27.7K ﹤0.01% 3042
2020
Q2 		$385K Buy
5,284
+2,376
+82% +$164K ﹤0.01% 2766
2020
Q1 		$153K Buy
2,908
+1,416
+95% +$94.6K ﹤0.01% 2866
2019
Q4 		$122K Hold
1,492
– – ﹤0.01% 3007
2019
Q3 		$84K Sell
1,492
-1,176
-44% -$88.1K ﹤0.01% 3103
2019
Q2 		$319K Buy
2,668
+380
+17% +$63.7K ﹤0.01% 2807
2019
Q1 		$421K Hold
2,288
– – ﹤0.01% 2597
2018
Q4 		$408K Buy
2,288
+356
+18% +$77.6K ﹤0.01% 2572
2018
Q3 		$618K Hold
1,932
– – ﹤0.01% 2543
2018
Q2 		$773K Buy
1,932
+172
+10% +$75.2K ﹤0.01% 2430
2018
Q1 		$631K Buy
1,760
+576
+49% +$214K ﹤0.01% 2447
2017
Q4 		$469K Buy
+1,184
New +$490K ﹤0.01% 2554
2016
Q2 		– Sell
-620
Closed -$40K – 2965
2016
Q1 		$40K Hold
620
– – ﹤0.01% 2883
2015
Q4 		$52K Hold
620
– – ﹤0.01% 2886
2015
Q3 		$63K Hold
620
– – ﹤0.01% 2906
2015
Q2 		$78K Buy
+620
New +$93.1K ﹤0.01% 2966

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein's ABEO Position: Q1 2026 in Review

AllianceBernstein held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 17,920 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3159.

AllianceBernstein first reported a position in ABEO in Q2 2015 and has held it in 22 quarters since. The position peaked at $773K in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • AllianceBernstein held 17,920 shares of Abeona Therapeutics worth $94.4K as of Q1 2026.
  • AllianceBernstein left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3159 holding.
  • AllianceBernstein first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 22 quarters since.
  • AllianceBernstein's Abeona Therapeutics position peaked at $773K in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.